Glycoprotein IIb/IIIa Receptor Antagonists

Glycoprotein IIb/IIIa receptor antagonists are a class of drugs that inhibit the function of the glycoprotein IIb/IIIa receptor, which is found on the surface of platelets. These drugs are used to prevent blood clots from forming in patients with acute coronary syndrome, unstable angina, or during percutaneous coronary intervention (PCI).

Examples of glycoprotein IIb/IIIa receptor antagonists include abciximab, eptifibatide, and tirofiban. These drugs work by blocking the binding of fibrinogen to the glycoprotein IIb/IIIa receptor, which prevents platelet aggregation and the formation of blood clots.

Glycoprotein IIb/IIIa receptor antagonists are typically administered intravenously and are used in combination with other antiplatelet agents, such as aspirin and clopidogrel. While these drugs are effective at preventing blood clots, they can also increase the risk of bleeding. Therefore, careful monitoring of patients is necessary to ensure that the benefits of these drugs outweigh the risks.

Based on his symptoms of night sweats, weight loss, fatigue, and splenomegaly, the patient is likely suffering from chronic myelogenous leukemia (CML). This type of leukemia is characterized by a specific translocation between chromosome 9 and 22, known as the Philadelphia chromosome. Other translocations are associated with different types of blood cancers, such as t(15;17) in acute promyelocytic leukemia, t(8;14) in Burkitt’s lymphoma, and t(11;14) in mantle cell lymphoma.

Genetics of Haematological Malignancies

Haematological malignancies are cancers that affect the blood, bone marrow, and lymphatic system. These cancers are often associated with specific genetic abnormalities, such as translocations. Here are some common translocations and their associated haematological malignancies:

– Philadelphia chromosome (t(9;22)): This translocation is present in more than 95% of patients with chronic myeloid leukaemia (CML). It results in the fusion of the Abelson proto-oncogene with the BCR gene on chromosome 22, creating the BCR-ABL gene. This gene codes for a fusion protein with excessive tyrosine kinase activity, which is a poor prognostic indicator in acute lymphoblastic leukaemia (ALL).

– t(15;17): This translocation is seen in acute promyelocytic leukaemia (M3) and involves the fusion of the PML and RAR-alpha genes.

– t(8;14): Burkitt’s lymphoma is associated with this translocation, which involves the translocation of the MYC oncogene to an immunoglobulin gene.

– t(11;14): Mantle cell lymphoma is associated with the deregulation of the cyclin D1 (BCL-1) gene.

– t(14;18): Follicular lymphoma is associated with increased BCL-2 transcription due to this translocation.

Understanding the genetic abnormalities associated with haematological malignancies is important for diagnosis, prognosis, and treatment.

Pyruvate Dehydrogenase and its Enzyme Complex

Pyruvate dehydrogenase is an enzyme complex that plays a crucial role in metabolism. It is composed of multiple copies of several enzymes, including E1, E2, and E3. E1, also known as pyruvate dehydrogenase, is located at the periphery of the molecule and requires thiamine pyrophosphate, a derivative of the vitamin thiamine, to function properly. E2, a transacetylase enzyme, is situated in the core of the molecule and requires lipoamide to work effectively. Lipoamide contains a thiol group that enables it to participate in redox reactions. E3, a dehydrogenase enzyme, is located at the periphery of the molecule and requires a molecule of FAD (flavin adenine dinucleotide) to function. Flavin structures are obtained from the vitamin riboflavin in the diet.

Thiamine is essential for normal pyruvate dehydrogenase activity, and it must be obtained from the diet as the body can only store relatively small amounts. Thiamine deficiency is common and can lead to a range of potentially serious complications, including Wernicke’s encephalopathy, Korsakoff’s psychosis, and peripheral neurological symptoms. Overall, the pyruvate dehydrogenase enzyme complex is under strict metabolic control and plays a critical role in energy production and metabolism.

Understanding Sickle-Cell Anaemia

Sickle-cell anaemia is a genetic disorder that occurs when an abnormal haemoglobin chain, known as HbS, is synthesized due to an autosomal recessive condition. This condition is more common in people of African descent, as the heterozygous condition offers some protection against malaria. In the UK, around 10% of Afro-Caribbean individuals are carriers of HbS. Symptoms in homozygotes typically do not develop until 4-6 months when the abnormal HbSS molecules take over from fetal haemoglobin.

The pathophysiology of sickle-cell anaemia involves the substitution of the polar amino acid glutamate with the non-polar valine in each of the two beta chains (codon 6) of haemoglobin. This substitution decreases the water solubility of deoxy-Hb, causing HbS molecules to polymerize and sickle in the deoxygenated state. HbAS patients sickle at p02 2.5 – 4 kPa, while HbSS patients sickle at p02 5 – 6 kPa. Sickle cells are fragile and can cause haemolysis, block small blood vessels, and lead to infarction.

To diagnose sickle-cell anaemia, haemoglobin electrophoresis is the definitive test. It is essential to understand the pathophysiology and symptoms of sickle-cell anaemia to provide appropriate care and management for affected individuals.

Typhoid is most commonly transmitted through contaminated food and water, as it is spread via the faecal-oral route. In rural villages where sanitation may be lacking, drinking water from wells can be a major source of transmission.

Burkholderia pseudomallei is typically associated with soil exposure, which is more commonly found in farming environments than Salmonella typhi.

Rabies, a virus transmitted through the saliva of infected animals, is a risk for those who come into contact with stray dogs.

Depending on the species of mosquito, bites can transmit diseases such as malaria or dengue fever, which are both viral haemorrhagic fevers.

Enteric fever, also known as typhoid or paratyphoid, is caused by Salmonella typhi and Salmonella paratyphi respectively. These bacteria are not normally found in the gut and are transmitted through contaminated food and water or the faecal-oral route. The symptoms of enteric fever include headache, fever, and joint pain, as well as abdominal pain and distension. Constipation is more common in typhoid than diarrhoea, and rose spots may appear on the trunk in 40% of patients with paratyphoid. Possible complications of enteric fever include osteomyelitis, gastrointestinal bleeding or perforation, meningitis, cholecystitis, and chronic carriage. Chronic carriage is more likely in adult females and occurs in 1% of cases.

If the external palatine vein is harmed during tonsillectomy, it can result in reactionary bleeding and is located adjacent to the tonsil.

Tonsil Anatomy and Tonsillitis

The tonsils are located in the pharynx and have two surfaces, a medial and lateral surface. They vary in size and are usually supplied by the tonsillar artery and drained by the jugulodigastric and deep cervical nodes. Tonsillitis is a common condition that is usually caused by bacteria, with group A Streptococcus being the most common culprit. It can also be caused by viruses. In some cases, tonsillitis can lead to the development of an abscess, which can distort the uvula. Tonsillectomy is recommended for patients with recurrent acute tonsillitis, suspected malignancy, or enlargement causing sleep apnea. The preferred technique for tonsillectomy is dissection, but it can be complicated by hemorrhage, which is the most common complication. Delayed otalgia may also occur due to irritation of the glossopharyngeal nerve.

The presence of factor V Leiden mutation leads to resistance to activated protein C.

The most probable cause of the patient’s recurrent DVTs and family history of thrombo-embolic events is factor V Leiden, which is the most common inherited thrombophilia. This mutation results in activated protein C resistance, as activated factor V is not inactivated as efficiently by protein C.

Antiphospholipid syndrome is an acquired thrombophilia that can cause both arterial and venous thromboses, and may present with thrombocytopenia. However, the patient’s positive family history and normal full blood count make this diagnosis less likely than factor V Leiden.

Protein C deficiency, protein S deficiency, and antithrombin III deficiency are all inherited thrombophilias, but they are less prevalent in the population compared to factor V Leiden. Therefore, they are less likely to be the underlying cause of the patient’s symptoms.

Understanding Factor V Leiden

Factor V Leiden is a common inherited thrombophilia, affecting around 5% of the UK population. It is caused by a mutation in the Factor V Leiden protein, resulting in activated factor V being inactivated 10 times more slowly by activated protein C than normal. This leads to activated protein C resistance, which increases the risk of venous thrombosis. Heterozygotes have a 4-5 fold risk of venous thrombosis, while homozygotes have a 10 fold risk, although the prevalence of homozygotes is much lower at 0.05%.

Despite its prevalence, screening for Factor V Leiden is not recommended, even after a venous thromboembolism. This is because a previous thromboembolism itself is a risk factor for further events, and specific management should be based on this rather than the particular thrombophilia identified.

Other inherited thrombophilias include Prothrombin gene mutation, Protein C deficiency, Protein S deficiency, and Antithrombin III deficiency. The table below shows the prevalence and relative risk of venous thromboembolism for each of these conditions.

Overall, understanding Factor V Leiden and other inherited thrombophilias can help healthcare professionals identify individuals at higher risk of venous thrombosis and provide appropriate management to prevent future events.

Condition | Prevalence | Relative risk of VTE
— | — | —
Factor V Leiden (heterozygous) | 5% | 4
Factor V Leiden (homozygous) | 0.05% | 10
Prothrombin gene mutation (heterozygous) | 1.5% | 3
Protein C deficiency | 0.3% | 10
Protein S deficiency | 0.1% | 5-10
Antithrombin III deficiency | 0.02% | 10-20

Bevacizumab is a monoclonal antibody that targets vascular endothelial growth factor (VEGF) and is used as a first-line treatment for the neovascular or exudative form of age-related macular degeneration (AMD). This form of AMD is characterized by the proliferation of abnormal blood vessels in the eye that leak blood and protein below the macula, causing damage to the photoreceptors. Bevacizumab blocks VEGF, which stimulates the growth of these abnormal vessels.

Fluocinolone is a corticosteroid that is used as an anti-inflammatory via intraocular injection in some eye conditions, but it does not affect VEGF. Laser photocoagulation is used to cauterize ocular blood vessels in several eye conditions, but it also does not affect VEGF. Verteporfin is a medication used as a photosensitizer prior to photodynamic therapy, which can be used in eye conditions with ocular vessel proliferation, but it is not an anti-VEGF drug.

Age-related macular degeneration (ARMD) is a common cause of blindness in the UK, characterized by degeneration of the central retina (macula) and the formation of drusen. The risk of ARMD increases with age, smoking, family history, and conditions associated with an increased risk of ischaemic cardiovascular disease. ARMD is classified into dry and wet forms, with the latter carrying the worst prognosis. Clinical features include subacute onset of visual loss, difficulties in dark adaptation, and visual hallucinations. Signs include distortion of line perception, the presence of drusen, and well-demarcated red patches in wet ARMD. Investigations include slit-lamp microscopy, colour fundus photography, fluorescein angiography, indocyanine green angiography, and ocular coherence tomography. Treatment options include a combination of zinc with anti-oxidant vitamins for dry ARMD and anti-VEGF agents for wet ARMD. Laser photocoagulation is also an option, but anti-VEGF therapies are usually preferred.

Withdrawal from alcohol can lead to hallucinations, often in the form of visual images such as rats or bugs crawling on or around the patient.

Understanding Korsakoff’s Syndrome

Korsakoff’s syndrome is a memory disorder that is commonly observed in individuals who have a history of alcoholism. This condition is caused by a deficiency in thiamine, which leads to damage and haemorrhage in the mammillary bodies of the hypothalamus and the medial thalamus. Korsakoff’s syndrome often follows untreated Wernicke’s encephalopathy, which is another condition caused by thiamine deficiency.

The primary features of Korsakoff’s syndrome include anterograde amnesia, which is the inability to acquire new memories, and retrograde amnesia. Individuals with this condition may also experience confabulation, which is the production of fabricated or distorted memories to fill gaps in their recollection.

Understanding Korsakoff’s syndrome is crucial for individuals who have a history of alcoholism or thiamine deficiency. Early diagnosis and treatment can help prevent further damage and improve the individual’s quality of life. Proper nutrition and abstinence from alcohol are essential for managing this condition.

A right superior homonymous quadrantanopia in the patient is caused by a lesion in the left inferior optic radiation located in the temporal lobe. The sudden onset indicates a possible stroke or vascular event. A superior homonymous quadrantanopia occurs when the contralateral inferior optic radiation is affected.

A lesion in the left superior optic radiation would result in a right inferior homonymous quadrantanopia, which is not the case here. Similarly, a lesion in the left optic tract would cause contralateral hemianopia, which is also not the diagnosis in this patient.

Understanding Visual Field Defects

Visual field defects can occur due to various reasons, including lesions in the optic tract, optic radiation, or occipital cortex. A left homonymous hemianopia indicates a visual field defect to the left, which is caused by a lesion in the right optic tract. On the other hand, homonymous quadrantanopias can be categorized into PITS (Parietal-Inferior, Temporal-Superior) and can be caused by lesions in the inferior or superior optic radiations in the temporal or parietal lobes.

When it comes to congruous and incongruous defects, the former refers to complete or symmetrical visual field loss, while the latter indicates incomplete or asymmetric visual field loss. Incongruous defects are caused by optic tract lesions, while congruous defects are caused by optic radiation or occipital cortex lesions. In cases where there is macula sparing, it is indicative of a lesion in the occipital cortex.

Bitemporal hemianopia, on the other hand, is caused by a lesion in the optic chiasm. The type of defect can indicate the location of the compression, with an upper quadrant defect being more common in inferior chiasmal compression, such as a pituitary tumor, and a lower quadrant defect being more common in superior chiasmal compression, such as a craniopharyngioma.

Understanding visual field defects is crucial in diagnosing and treating various neurological conditions. By identifying the type and location of the defect, healthcare professionals can provide appropriate interventions to improve the patient’s quality of life.